MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
A Study of Pyridostigmine in Postural Tachycardia Syndrome
Phase 2
Recruiting
- Conditions
- Postural Tachycardia Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-12-08
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 50
- Registration Number
- NCT00409435
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase 1
Completed
- Conditions
- Primary Peritoneal Cavity CancerOvarian Cancer
- Interventions
- Biological: carcinoembryonic antigen-expressing measles virusBiological: oncolytic measles virus encoding thyroidal sodium iodide symporterGenetic: reverse transcriptase-polymerase chain reactionOther: laboratory biomarker analysis
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 37
- Registration Number
- NCT00408590
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- First Posted Date
- 2006-12-05
- Last Posted Date
- 2019-05-02
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 19
- Registration Number
- NCT00407550
- Locations
- 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
Phase 1
Completed
- Conditions
- Left Ventricular Diastolic Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 41
- Registration Number
- NCT00405548
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function
Phase 1
Completed
- Conditions
- Asymptomatic Systolic DysfunctionHeart Failure
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2014-03-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 37
- Registration Number
- NCT00405639
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2015-10-27
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT00405340
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
CellCept in p-ANCA Vasculitis
Phase 1
Completed
- Conditions
- MPO-ANCA VasculitisMicroscopic Polyangiitis
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 18
- Registration Number
- NCT00405860
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
St. John's Wort for Tobacco Cessation
Phase 2
Completed
- Conditions
- Nicotine DependenceSmoking
- Interventions
- Drug: St. John's Wort-900 mg/dayDrug: St. John's Wort-1800mg/dayDrug: Placebo
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2011-04-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 118
- Registration Number
- NCT00405912
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Emergency Department Telephone Quitline
Not Applicable
Completed
- Conditions
- Tobacco Dependence
- First Posted Date
- 2006-11-01
- Last Posted Date
- 2010-01-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 40
- Registration Number
- NCT00394420
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
Phase 3
Completed
- Conditions
- Smokeless Tobacco Use
- Interventions
- Drug: Placebo lozenge
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2013-04-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 270
- Registration Number
- NCT00392379
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Oregon Research Institute, Eugene, Oregon, United States
© Copyright 2025. All Rights Reserved by MedPath